Biopharma AI
By
Will AI-Powered Prior Authorization Change How Medicare Care Is Delivered?
December 2025 — Medicare is preparing to introduce artificial intelligence–driven prior authorization reviews for certain medical services beginning…
How Is Senhwa Biosciences Using AI and Strategic Collaborations to Shape the Next Generation of Immuno-Oncology?
TAIPEI and SAN DIEGO — Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on first-in-class therapies for oncology,…
Will the European Commission’s New Health Policy Package Accelerate Biotech, AI, and Medical Device Innovation?
The European Commission has unveiled a new health policy package to strengthen innovation, competitiveness, and resilience across the…
Are Galux and Boehringer Ingelheim Pioneering AI in Precision Protein Design?
December 17, 2025 — Galux, a South Korean biotech company focused on AI-driven protein therapeutics, has entered a…
Is AI Poised to Replace the Traditional Drug Discovery Lab? Nvidia CEO Signals a Paradigm Shift in Pharma R&D
23 January 2026 Executive Summary Nvidia CEO Jensen Huang has underscored the transformative potential of artificial intelligence in…
Can AI Become the Backbone of Global Health Equity? Gates Foundation and OpenAI Launch $50 Million Horizon1000 Initiative in Africa
Executive Summary The Bill & Melinda Gates Foundation and OpenAI have announced a $50 million public–private initiative, Horizon1000,…
